2021 U-M Kellogg Eye Center Annual Report

Page 17

Clinical Research Update: Patient Perspectives After a year during which COVID-19 restrictions curtailed many aspects of its day-to-day operations, the Kellogg Clinical Research Center (KCRC) is once again humming with activity. KCRC research coordinators currently manage 54 sponsor-initiated clinical studies involving 15 faculty members. Another 13 studies will begin within the next year, with three more faculty investigators. “While we had to do things differently during the pandemic, we never lost our focus on providing exceptional service and support to our investigators and sponsors, and especially

Callie Gordon, COA, OSC, Clinical Research Coordinator, with Brandon Gibbons

OF COURSE, I HOPE

I’LL EVENTUALLY BENEFIT FROM

letter from Kellogg, notifying him

TREATMENTS THAT COME OUT OF

that he met the initial criteria to be considered for a study.

to our valued research volunteers,”

CLINICAL RESEARCH. BUT IN THE

says KCRC Medical Director Grant

MEANTIME, I’M GLAD TO PLAY SOME

Two recent study participants

Comer, M.D., M.S.

SMALL ROLE IN THE PROCESS.

typify the selflessness and commitment that make research volunteers so special.

— Brandon Gibbons

Both live with rare, genetic eye conditions that cause progressive vision loss; and for

a leading institution with access to the latest advances, including experimental treatments. My wife and I discussed it and decided to look into it.” KCRC Clinical Research Coordinator

a comprehensive initial screening, and has

Brandon Gibbons, 27, began seeing an ophthalat age 13. He and his parents first traveled to the Kellogg Eye

much thought,” he admits. “But I came to Kellogg to connect with

Stephanie Wietholter walked Fries through

which there are no effective treatments. mologist close to his home in Florida after being diagnosed

“At first, I didn’t give it

remained his primary point of contact. “Because many trials require frequent and lengthy visits,

Center in 2008. He returned to Kellogg regularly until starting

we get to know our volunteers very well,” she says. “That’s

college in 2012.

one of the best parts of what we do – building relationships

Curious about any new advances that may have been available, Brandon again traveled from his home in Florida to the

with wonderful patients like Brice and their families.” “From my first trip to Kellogg through my time in the study,

Kellogg Eye Center in 2017. During his examination, he learned

everyone has gone out of their way to help and encourage me

about a clinical trial and decided to participate.

and my family,” says Fries. “It has made a lasting impression

Gibbons works as an ophthalmic technician, and is studying for a graduate degree in pharmacology. “I’ve always been fasci-

on us.” Both volunteers know that their participation in these stud-

nated by science and research, and I’ve always been impressed

ies will not directly improve their vision. Yet both agree that the

with the high degree of professionalism and skill I encounter at

experience is one they would recommend to others.

Kellogg,” he says. “So stepping up to participate in a clinical study was not a difficult decision for me.” Clinical Research Coordinator Callie Gordon is Gibbons’

“I knew from the start that this experience is about helping people down the road, not myself,” Brandon Gibbons says. “Of course, I hope I’ll eventually benefit from treatments that

primary contact at the KCRC. “All of our trial participants are

come out of clinical research. But in the meantime, I’m glad to

terrific, but Brandon was especially engaged and motivated,”

play some small role in the process.”

she says. “It’s not every day that a patient already ‘speaks our language.’” Brice Fries, 37, began traveling to Kellogg from his home in northern Ohio in 2011 for annual exams to monitor his

Brice Fries agrees. “Because I had such a high level of trust in my Kellogg care team, I had no reservations about volunteering. It’s especially important for people like us, with conditions that are currently untreatable, to get involved.”

condition. He first learned about clinical trial possibilities in 15


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Toward a Therapeutic Target for Proliferative Vitreoretinopathy

2min
page 25

State-of-the-Science Microscope Gives Kellogg Researchers New Edge

2min
page 25

Michigan Medicine to Establish Neural Engineering Training Program

2min
page 21

Endocrine Society Award

1min
page 21

Leading on the National Stage

2min
page 15

Marshall Parks Lecture at AAO

1min
page 13

Prioritizing Communication for Patient Safety

2min
page 13

New Faculty Members

3min
page 42

Alumni Highlights

4min
page 39

Recognizing Distinguished Alumni Richard Gutow, M.D., and Gary Gutow, M.D.

6min
pages 36-37

Guarding Photoreceptor Metabolism to Prevent Vision Loss in Inherited Retinal Diseases

2min
page 31

Big Data, Collaboration, and Impact

3min
page 35

A Visionary Legacy

3min
page 33

Eyes on the Future

3min
page 34

Kellogg’s Latest Heed Fellows

3min
page 32

U-M Learners Produce Online Newsletter

3min
page 29

Next-Generation Tools to Treat Abnormal New Ocular Blood Vessels

3min
page 28

Genetically-Modified Occludin Shown to Protect Against Diabetes-Related Vision Loss

2min
page 30

Innovation in Action

3min
page 24

New Pediatric Ophthalmology Fellowship in Ghana

3min
page 27

Kellogg Addresses Technician Shortage with Ongoing Training Program

2min
page 26

Kellogg Researcher Launches First of-its-Kind Study of Health and Aging in Kenya

2min
page 23

A New Regulator of Retinal Angiogenesis Discovered

2min
page 22

Lipid Droplets May Protect Against AMD

2min
page 20

Mapping the Genetic Landscape of Nanophthalmos

2min
page 19

Training Eye Disease Researchers in India

2min
page 18

Kellogg Leads International Team Linking Family’s Symptoms to Rare, Inherited Syndrome

4min
pages 14-15

Clinical Research Update: Patient Perspectives

4min
page 17

Finding New Pathways for the Treatment of Choroideremia

2min
page 16

Finding a Personalized Solution for Dry Eye

3min
page 12

Vitreoretinal Lymphoma: from Symptoms to Diagnosis to Treatment

5min
pages 4-5

In it Together

5min
pages 10-11

Collaborating to Deliver Specialized Care

3min
pages 8-9

Steno North American Fellowship

2min
page 5

The Chair’s Perspective

2min
page 3

Kellogg Offers Multiple Options for Limbal Stem Cell Deficiency

3min
page 7

COVID-19 Transmission Risk in Cornea Transplantation

2min
page 9

NIH-Funded Pilot Program Addresses Disparities in Glaucoma Care

3min
page 6
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.